• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 Cβ 缺乏通过 M1 巨噬细胞极化和上调间皮蛋白激酶 Cα 增加葡萄糖介导的腹膜损伤。

Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha.

机构信息

Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.

Phenos, Hannover, Germany.

出版信息

Nephrol Dial Transplant. 2019 Jun 1;34(6):947-960. doi: 10.1093/ndt/gfy282.

DOI:10.1093/ndt/gfy282
PMID:30247663
Abstract

BACKGROUND

Peritoneal membrane (PM) damage during peritoneal dialysis (PD) is mediated largely by high glucose (HG)-induced pro-inflammatory and neo-angiogenic processes, resulting in PM fibrosis and ultrafiltration failure. We recently demonstrated a crucial role for protein kinase C (PKC) isoform α in mesothelial cells.

METHODS

In this study we investigate the role of PKCβ in PM damage in vitro using primary mouse peritoneal macrophages (MPMΦ), human macrophages (HMΦ) and immortalized mouse peritoneal mesothelial cells (MPMCs), as well as in vivo using a chronic PD mouse model.

RESULTS

We demonstrate that PKCβ is the predominant classical PKC isoform expressed in primary MPMΦ and its expression is up-regulated in vitro under HG conditions. After in vitro lipopolysaccharides stimulation PKCβ-/- MPMΦ demonstrates increased levels of interleukin 6 (IL-6), tumour necrosis factor α, and monocyte chemoattractant protein-1 and drastically decrease IL-10 release compared with wild-type (WT) cells. In vivo, catheter-delivered treatment with HG PD fluid for 5 weeks induces PKCβ up-regulation in omentum of WT mice and results in inflammatory response and PM damage characterized by fibrosis and neo-angiogenesis. In comparison to WT mice, all pathological changes are strongly aggravated in PKCβ-/- animals. Underlying molecular mechanisms involve a pro-inflammatory M1 polarization shift of MPMΦ and up-regulation of PKCα in MPMCs of PKCβ-/- mice. Finally, we demonstrate PKCβ involvement in HG-induced polarization processes in HMΦ.

CONCLUSIONS

PKCβ as the dominant PKC isoform in MPMΦ is up-regulated by HG PD fluid and exerts anti-inflammatory effects during PD through regulation of MPMΦ M1/M2 polarization and control of the dominant mesothelial PKC isoform α.

摘要

背景

腹膜透析(PD)过程中腹膜(PM)损伤主要由高糖(HG)诱导的促炎和新生血管过程介导,导致 PM 纤维化和超滤衰竭。我们最近证明了蛋白激酶 C(PKC)同工型α在间皮细胞中的关键作用。

方法

在这项研究中,我们使用原代小鼠腹膜巨噬细胞(MPMΦ)、人巨噬细胞(HMΦ)和永生化小鼠腹膜间皮细胞(MPMCs)在体外,以及在慢性 PD 小鼠模型中在体内研究 PKCβ 在 PM 损伤中的作用。

结果

我们证明 PKCβ 是原代 MPMΦ 中表达的主要经典 PKC 同工型,其表达在 HG 条件下体外上调。在体外脂多糖刺激后,PKCβ-/-MPMΦ 表现出更高水平的白细胞介素 6(IL-6)、肿瘤坏死因子 α 和单核细胞趋化蛋白-1,与 WT 细胞相比,IL-10 释放明显减少。在体内,导管输送 HG PD 液 5 周会诱导 WT 小鼠网膜中 PKCβ 的上调,并导致炎症反应和 PM 损伤,其特征为纤维化和新生血管形成。与 WT 小鼠相比,所有病理变化在 PKCβ-/-动物中都强烈加重。潜在的分子机制涉及 MPMΦ 的促炎 M1 极化转变和 PKCβ-/-小鼠 MPMC 中 PKCα 的上调。最后,我们证明 PKCβ 参与了 HG 诱导的 HMΦ 极化过程。

结论

作为 MPMΦ 中主要的 PKC 同工型,HG PD 液可上调 PKCβ,并通过调节 MPMΦ M1/M2 极化和控制主导的间皮 PKC 同工型α,在 PD 过程中发挥抗炎作用。

相似文献

1
Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha.蛋白激酶 Cβ 缺乏通过 M1 巨噬细胞极化和上调间皮蛋白激酶 Cα 增加葡萄糖介导的腹膜损伤。
Nephrol Dial Transplant. 2019 Jun 1;34(6):947-960. doi: 10.1093/ndt/gfy282.
2
Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.蛋白激酶 Cα 抑制可预防慢性腹腔暴露于高糖透析液的小鼠模型中的腹膜损伤。
Kidney Int. 2016 Jun;89(6):1253-67. doi: 10.1016/j.kint.2016.01.025. Epub 2016 Mar 25.
3
A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.M1 巨噬细胞在腹膜透析相关性纤维化中的发病机制作用。
Mol Immunol. 2018 Feb;94:131-139. doi: 10.1016/j.molimm.2017.12.023. Epub 2018 Jan 4.
4
The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells.单核细胞趋化蛋白-1(MCP-1)/CCR2 系统参与了腹膜透析相关的腹膜间皮细胞上皮-间充质转化。
Lab Invest. 2012 Dec;92(12):1698-711. doi: 10.1038/labinvest.2012.132. Epub 2012 Sep 24.
5
Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment.接受腹膜透析液治疗的C反应蛋白转基因小鼠的腹膜炎症和纤维化
Nephrology (Carlton). 2017 Feb;22(2):125-132. doi: 10.1111/nep.12741.
6
Effect of high glucose on peritoneal mesothelial cell biology.高糖对腹膜间皮细胞生物学的影响。
Perit Dial Int. 2000;20 Suppl 2:S15-8.
7
Role of allograft inflammatory factor-1 in the regulation of inflammation and oxidative stress in primary peritoneal mesothelial cells.同种异体炎症因子-1 在调节原发性腹膜间皮细胞炎症和氧化应激中的作用。
Cell Biol Int. 2019 May;43(5):495-505. doi: 10.1002/cbin.11115. Epub 2019 Mar 12.
8
SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.腹腔内给予达格列净抑制 SGLT2 可减轻慢性高糖透析液腹腔暴露小鼠模型中的腹膜纤维化和超滤衰竭。
Biomolecules. 2020 Nov 19;10(11):1573. doi: 10.3390/biom10111573.
9
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.过氧化物酶体增殖物激活受体-γ 激动剂罗格列酮可保护腹膜免受透析液损伤。
Lab Invest. 2010 Oct;90(10):1517-32. doi: 10.1038/labinvest.2010.111. Epub 2010 Jun 7.
10
Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.奈必洛尔,一种β1肾上腺素能阻滞剂,可预防腹膜透析过程中引起的腹膜损伤。
Oncotarget. 2016 May 24;7(21):30133-46. doi: 10.18632/oncotarget.8780.

引用本文的文献

1
Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis.腹膜巨噬细胞参与透析相关性腹膜纤维化发病机制的潜在机制及新型治疗策略。
Front Immunol. 2024 Dec 19;15:1507265. doi: 10.3389/fimmu.2024.1507265. eCollection 2024.
2
Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma.腹膜透析引起的腹膜无菌性炎症:聚焦免疫细胞与腹膜基质的相互作用。
Front Immunol. 2024 May 8;15:1387292. doi: 10.3389/fimmu.2024.1387292. eCollection 2024.
3
Intercellular communication in peritoneal dialysis.
腹膜透析中的细胞间通讯
Front Physiol. 2024 Feb 8;15:1331976. doi: 10.3389/fphys.2024.1331976. eCollection 2024.
4
Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation.基于网络药理学和实验验证的黄芩素在腹膜透析相关腹膜纤维化中的治疗机制
Front Pharmacol. 2023 May 17;14:1153503. doi: 10.3389/fphar.2023.1153503. eCollection 2023.
5
Mechanisms of Peritoneal Mesothelial Cells in Peritoneal Adhesion.腹膜间皮细胞在腹膜粘连中的作用机制。
Biomolecules. 2022 Oct 17;12(10):1498. doi: 10.3390/biom12101498.
6
Angiotensin II type 2 receptor prevents extracellular matrix accumulation in human peritoneal mesothelial cell by ameliorating lipid disorder via LOX-1 suppression.血管紧张素 II 型受体通过抑制 LOX-1 改善脂质紊乱来防止人腹膜间皮细胞细胞外基质积聚。
Ren Fail. 2022 Dec;44(1):1687-1697. doi: 10.1080/0886022X.2022.2133729.
7
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis.腹膜纤维化:腹膜透析治疗新靶点。
Int J Mol Sci. 2022 Apr 27;23(9):4831. doi: 10.3390/ijms23094831.
8
Ameliorative role of SIRT1 in peritoneal fibrosis: an in vivo and in vitro study.SIRT1在腹膜纤维化中的改善作用:一项体内和体外研究
Cell Biosci. 2021 Apr 27;11(1):79. doi: 10.1186/s13578-021-00591-8.
9
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions.腹膜纤维化的机制:聚焦免疫细胞-腹膜基质细胞相互作用。
Front Immunol. 2021 Mar 29;12:607204. doi: 10.3389/fimmu.2021.607204. eCollection 2021.
10
TLR4 Response to LPS Is Reinforced by Urokinase Receptor.尿激酶受体增强 TLR4 对 LPS 的反应。
Front Immunol. 2020 Dec 9;11:573550. doi: 10.3389/fimmu.2020.573550. eCollection 2020.